Evidence map›Paper›PMID 40016196›Full record

ArticleNature communications2025

Molecular basis of host recognition of human coronavirus 229E.

Yu-Xi Tsai, Yu-Chun Chien, Min-Feng Hsu, Kay-Hooi Khoo, Shang-Te Danny Hsu

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu-Xi TsaiInstitute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.ORCID http://orcid.org/0000-0002-5529-657X
Yu-Chun ChienInstitute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.ORCID http://orcid.org/0000-0002-2485-2932
Min-Feng HsuInstitute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.
Kay-Hooi KhooInstitute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.ORCID http://orcid.org/0000-0003-2906-406X
Shang-Te Danny HsuInstitute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan. sthsu@gate.sinica.edu.tw.ORCID http://orcid.org/0000-0002-7231-0185

Funding

Academia Sinica AS-IDR-111-03Academia Sinica AS-IDR-112-04Academia Sinica AS-IDR-114-S01Academia Sinica AS-IV-114-L04
6 · The paper itself

Abstract

Human coronavirus 229E (HCoV-229E) is the earliest CoV found to infect humans. It binds to the human aminopeptidase N (hAPN) through the receptor binding domain (RBD) of its spike (S) protein to achieve host recognition. We present the cryo-electron microscopy structure of two HCoV-229E S protein in complex with a dimeric hAPN to provide structural insights on how the HCoV-229E S protein opens up its RBD to engage with its host receptor, information that is currently missing among alphacoronaviruses to which HCoV-229E belong. We quantitatively profile the glycosylation of HCoV-229E S protein and hAPN to deduce the glyco-shielding effects pertinent to antigenicity and host recognition. Finally, we present an atomic model of fully glycosylated HCoV-229E S in complex with hAPN anchored on their respective membrane bilayers to recapitulate the structural basis of the first step of host infection by HCoV-229E.

Indexed as

Coronavirus 229E, HumanHost Microbial InteractionsModels, MolecularSpike Glycoprotein, CoronavirusCD13 AntigensCryoelectron MicroscopyGlycosylationHumansImaging, Three-DimensionalLiquid Chromatography-Mass SpectrometryMicroscopy, Electron, TransmissionProtein BindingProtein Structure, QuaternaryCD13 AntigensSpike Glycoprotein, Coronavirus

Identifiers

PMID40016196
PMCPMC11868633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.